BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32839832)

  • 21. Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study.
    Tamagawa H; Numata M; Aoyama T; Kazama K; Atsumi Y; Iguchi K; Sawazaki S; Sato S; Kano K; Ohshima T; Yamada T; Godai T; Higuchi A; Saeki H; Yukawa N; Rino Y
    In Vivo; 2021; 35(6):3483-3488. PubMed ID: 34697185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].
    Jin J; Deng J; Liang H; Sun C; Guo X; Guo J; Bai H; Liu H; Zhang N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):53-60. PubMed ID: 29354900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
    Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
    Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.
    Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
    J Cancer Res Clin Oncol; 2006 Dec; 132(12):781-5. PubMed ID: 16804723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
    Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
    J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy.
    Migita K; Matsumoto S; Wakatsuki K; Ito M; Kunishige T; Nakade H; Kitano M; Nakatani M; Kanehiro H
    Surg Today; 2017 Aug; 47(8):1018-1026. PubMed ID: 28251372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?
    Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
    Gastric Cancer; 2019 Nov; 22(6):1274-1284. PubMed ID: 30945120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of infectious complications after curative gastric cancer surgery.
    Han WH; Oh YJ; Eom BW; Yoon HM; Kim YW; Ryu KW
    Eur J Surg Oncol; 2020 Jul; 46(7):1233-1238. PubMed ID: 32362466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes.
    Liu Y; Zhang KC; Huang XH; Xi HQ; Gao YH; Liang WQ; Wang XX; Chen L
    World J Gastroenterol; 2018 Jan; 24(2):257-265. PubMed ID: 29375211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?
    Sandø AD; Grønbech JE; Bringeland EA
    Acta Oncol; 2023 Dec; 62(12):1846-1853. PubMed ID: 37903117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
    Arima K; Hashimoto D; Okabe H; Inoue R; Kaida T; Higashi T; Taki K; Nitta H; Hayashi H; Chikamoto A; Beppu T; Baba H
    Surg Today; 2016 Jul; 46(7):792-7. PubMed ID: 26302976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.
    Kano M; Hayano K; Hayashi H; Hanari N; Gunji H; Toyozumi T; Murakami K; Uesato M; Ota S; Matsubara H
    Ann Surg Oncol; 2019 Jun; 26(6):1805-1813. PubMed ID: 30977014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    Tong Y; Zhao Y; Shan Z; Zhang J
    BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer.
    Mizuno A; Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Surg; 2016; 33(2):121-8. PubMed ID: 26745751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
    Greenleaf EK; Hollenbeak CS; Wong J
    Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
    Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
    Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse impact of postoperative intra-abdominal infectious complications on cancer recurrence-related survival after curative gastric cancer surgery.
    Takebayashi K; Murata S; Kaida S; Yamaguchi T; Otake R; Miyake T; Ueki T; Kojima M; Iida H; Maehira H; Mori H; Shimizu T; Tani M
    Am J Surg; 2022 Sep; 224(3):949-954. PubMed ID: 35599072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and Long-Term Outcomes in Malnourished Patients After Laparoscopic or Open Radical Gastrectomy.
    Zheng HL; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Tu RH; Huang CM
    World J Surg; 2018 Jan; 42(1):195-203. PubMed ID: 28741200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.